A 48-year-old patient affected with congenital generalized lipodystrophy type 4 failed to respond to two doses of the BNT162b2 vaccine, consisting of lipid nanoparticle encapsulated mRNA. As the disease is caused by biallelic variants of CAVIN1, a molecule indispensable for lipid endocytosis and regulation, we complemented the vaccination cycle with a single dose of the Ad26.COV2 vaccine. Adenovirus-based vaccine entry is mediated by the interaction with adenovirus receptors and transport occurs in clathrin-coated pits. Ten days after Ad26.COV2 administration, S- and RBD-specific antibodies and high-affinity memory B cells increased significantly to values close to those observed in Health Care Worker controls.
Keywords: CAVIN1; SARS-CoV-2 vaccine; case report; congenital generalized lipodystrophy type 4; memory B cells.
Copyright © 2022 Zaffina, Piano Mortari, Di Prinzio, Cappa, Novelli, Agolini, Raponi, Dallapiccola, Locatelli, Perno and Carsetti.